These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 29157392)

  • 1. Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair.
    Lemus HN; Warrington AE; Rodriguez M
    Neurol Clin; 2018 Feb; 36(1):1-11. PubMed ID: 29157392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
    Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
    Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting oligodendrocyte protection and remyelination in multiple sclerosis.
    Zhang J; Kramer EG; Mahase S; Dutta DJ; Bonnamain V; Argaw AT; John GR
    Mt Sinai J Med; 2011; 78(2):244-57. PubMed ID: 21425268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary influence on central nervous system myelin production, injury, and regeneration.
    Langley MR; Triplet EM; Scarisbrick IA
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165779. PubMed ID: 32224154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unified cell biological perspective on axon-myelin injury.
    Simons M; Misgeld T; Kerschensteiner M
    J Cell Biol; 2014 Aug; 206(3):335-45. PubMed ID: 25092654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological aspects of axon injury in multiple sclerosis.
    Howe CL
    Curr Top Microbiol Immunol; 2008; 318():93-131. PubMed ID: 18219816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K; Brück W; Kuhlmann T
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin repair strategies: a cellular view.
    Gallo V; Armstrong RC
    Curr Opin Neurol; 2008 Jun; 21(3):278-83. PubMed ID: 18451710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
    Siffrin V; Vogt J; Radbruch H; Nitsch R; Zipp F
    Trends Neurosci; 2010 Apr; 33(4):202-10. PubMed ID: 20153532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial changes within axons in multiple sclerosis: an update.
    Campbell GR; Ohno N; Turnbull DM; Mahad DJ
    Curr Opin Neurol; 2012 Jun; 25(3):221-30. PubMed ID: 22543429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Nikić I; Merkler D; Sorbara C; Brinkoetter M; Kreutzfeldt M; Bareyre FM; Brück W; Bishop D; Misgeld T; Kerschensteiner M
    Nat Med; 2011 Apr; 17(4):495-9. PubMed ID: 21441916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.